Using Liquid Biopsy Insights to Optimize Dosage Regimes & Personalize Treatment for Better Patient Outcomes
Time: 2:00 pm
day: Conference Day 2
Details:
- Understanding how ctDNA can inform dosage options, and key takeaways from Project Optimus
- Can ctDNA confidently prevent unnecessary treatment and reduce high-dose exposure and minimizing toxicity?
- How can liquid-biopsy-enhanced longitudinal monitoring be effective in adjusting dosage dynamically throughout treatment
Dosage Regime
